Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRCS -- Ignore unavailable to you. Want to Upgrade?

To: a.m. fisher who wrote (60)	12/20/2001 11:55:16 AM
From: tuck	Read Replies (1) \| Respond to of 78

>>Medical Castration The ability of the testicles to make testosterone can also be stopped without surgery. Medical castration shuts off the supply of testosterone by the testicles and achieves the same result as surgical castration. Medical castration involves monthly injections of leuprolide or goserelin. These medications are also referred to as LHRH agonists. An LHRH agonist helps reduce the amount of testosterone similar to the surgical procedure. Side effects usually include hot flashes, impotence, breast enlargement and tenderness, loss of sex drive and nausea.<< snip spfulford.com Was looking for news that caused this bounce on a bleak morning, since I wrote December 5 calls. Can't find any, but I have noticed that insiders are selling even down here. Gefter must be giving some expensive Christmas gifts or something. He exercised options at 27 cents and prmoptly sold in the $4s. With that going on, I didn't think I was going to have to roll my calls forward. But unless this is a head fake, it looks like I will. It's coming on pretty good volume, so maybe it's a major taking a position. Nice thought. Cheers, Tuck